Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients

Sung Woo Lee, Mi Yeon Yu, Seon Ha Baek, Shin Young Ahn, Sejoong Kim, Ki Young Na, Dong Wan Chae, Ho Jun Chin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND/AIMS: Patients with minimal change disease (MCD) have a high relapse rate, which results in many complications. Identifying the risk factors for relapse is crucial, but little is known about these factors. Therefore, we performed the current study to determine the factors related to relapse in this patient population.

METHODS: We retrospectively analyzed 51 adult patients with biopsy-proven primary MCD treated between 2003 and 2013. The demographic, physiologic, laboratory and therapeutic data were gathered from the electronic medical records database. Lesions of the glomerulus, tubulointerstitium and vasculature were analyzed for associations with relapse.

RESULTS: During a median 50.9 months, 96.1% (49 of 51) of patients had achieved complete remission, and the rest ultimately achieved at least partial remission. A total of 56.9% (29 of 51) patients experienced at least 1 episode of relapse after the first remission. Patients with relapse had a higher rate of glomerular hypertrophy (GH; 34.5%) than those without relapse (9.1%; p < 0.05). After adjusting for confounders, GH was associated with increased odds of relapse (OR 15.992; 95% CI 1.537-166.362; p = 0.02). In a subgroup analysis according to median age, sex and tubulointerstitial (TI) lesions, the association between GH and relapse was evident only in men and in the group with TI lesions.

CONCLUSION: GH is associated with relapse in adult patients with MCD, particularly in men and in those with TI lesions. Frequent monitoring and early intervention are needed in these groups. Future large prospective cohort studies are needed to confirm the study results.

Original languageEnglish
Pages (from-to)43-50
Number of pages8
JournalNephron
Volume132
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Fingerprint

Lipoid Nephrosis
Hypertrophy
Recurrence
Electronic Health Records
Cohort Studies
Demography
Databases
Prospective Studies

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Urology
  • Physiology (medical)

Cite this

Lee, S. W., Yu, M. Y., Baek, S. H., Ahn, S. Y., Kim, S., Na, K. Y., ... Chin, H. J. (2016). Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients. Nephron, 132(1), 43-50. https://doi.org/10.1159/000442680

Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients. / Lee, Sung Woo; Yu, Mi Yeon; Baek, Seon Ha; Ahn, Shin Young; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Chin, Ho Jun.

In: Nephron, Vol. 132, No. 1, 01.01.2016, p. 43-50.

Research output: Contribution to journalArticle

Lee, SW, Yu, MY, Baek, SH, Ahn, SY, Kim, S, Na, KY, Chae, DW & Chin, HJ 2016, 'Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients', Nephron, vol. 132, no. 1, pp. 43-50. https://doi.org/10.1159/000442680
Lee, Sung Woo ; Yu, Mi Yeon ; Baek, Seon Ha ; Ahn, Shin Young ; Kim, Sejoong ; Na, Ki Young ; Chae, Dong Wan ; Chin, Ho Jun. / Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients. In: Nephron. 2016 ; Vol. 132, No. 1. pp. 43-50.
@article{0eaca8aa46714aa79c55f0d08d57bde8,
title = "Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients",
abstract = "BACKGROUND/AIMS: Patients with minimal change disease (MCD) have a high relapse rate, which results in many complications. Identifying the risk factors for relapse is crucial, but little is known about these factors. Therefore, we performed the current study to determine the factors related to relapse in this patient population.METHODS: We retrospectively analyzed 51 adult patients with biopsy-proven primary MCD treated between 2003 and 2013. The demographic, physiologic, laboratory and therapeutic data were gathered from the electronic medical records database. Lesions of the glomerulus, tubulointerstitium and vasculature were analyzed for associations with relapse.RESULTS: During a median 50.9 months, 96.1{\%} (49 of 51) of patients had achieved complete remission, and the rest ultimately achieved at least partial remission. A total of 56.9{\%} (29 of 51) patients experienced at least 1 episode of relapse after the first remission. Patients with relapse had a higher rate of glomerular hypertrophy (GH; 34.5{\%}) than those without relapse (9.1{\%}; p < 0.05). After adjusting for confounders, GH was associated with increased odds of relapse (OR 15.992; 95{\%} CI 1.537-166.362; p = 0.02). In a subgroup analysis according to median age, sex and tubulointerstitial (TI) lesions, the association between GH and relapse was evident only in men and in the group with TI lesions.CONCLUSION: GH is associated with relapse in adult patients with MCD, particularly in men and in those with TI lesions. Frequent monitoring and early intervention are needed in these groups. Future large prospective cohort studies are needed to confirm the study results.",
author = "Lee, {Sung Woo} and Yu, {Mi Yeon} and Baek, {Seon Ha} and Ahn, {Shin Young} and Sejoong Kim and Na, {Ki Young} and Chae, {Dong Wan} and Chin, {Ho Jun}",
year = "2016",
month = "1",
day = "1",
doi = "10.1159/000442680",
language = "English",
volume = "132",
pages = "43--50",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients

AU - Lee, Sung Woo

AU - Yu, Mi Yeon

AU - Baek, Seon Ha

AU - Ahn, Shin Young

AU - Kim, Sejoong

AU - Na, Ki Young

AU - Chae, Dong Wan

AU - Chin, Ho Jun

PY - 2016/1/1

Y1 - 2016/1/1

N2 - BACKGROUND/AIMS: Patients with minimal change disease (MCD) have a high relapse rate, which results in many complications. Identifying the risk factors for relapse is crucial, but little is known about these factors. Therefore, we performed the current study to determine the factors related to relapse in this patient population.METHODS: We retrospectively analyzed 51 adult patients with biopsy-proven primary MCD treated between 2003 and 2013. The demographic, physiologic, laboratory and therapeutic data were gathered from the electronic medical records database. Lesions of the glomerulus, tubulointerstitium and vasculature were analyzed for associations with relapse.RESULTS: During a median 50.9 months, 96.1% (49 of 51) of patients had achieved complete remission, and the rest ultimately achieved at least partial remission. A total of 56.9% (29 of 51) patients experienced at least 1 episode of relapse after the first remission. Patients with relapse had a higher rate of glomerular hypertrophy (GH; 34.5%) than those without relapse (9.1%; p < 0.05). After adjusting for confounders, GH was associated with increased odds of relapse (OR 15.992; 95% CI 1.537-166.362; p = 0.02). In a subgroup analysis according to median age, sex and tubulointerstitial (TI) lesions, the association between GH and relapse was evident only in men and in the group with TI lesions.CONCLUSION: GH is associated with relapse in adult patients with MCD, particularly in men and in those with TI lesions. Frequent monitoring and early intervention are needed in these groups. Future large prospective cohort studies are needed to confirm the study results.

AB - BACKGROUND/AIMS: Patients with minimal change disease (MCD) have a high relapse rate, which results in many complications. Identifying the risk factors for relapse is crucial, but little is known about these factors. Therefore, we performed the current study to determine the factors related to relapse in this patient population.METHODS: We retrospectively analyzed 51 adult patients with biopsy-proven primary MCD treated between 2003 and 2013. The demographic, physiologic, laboratory and therapeutic data were gathered from the electronic medical records database. Lesions of the glomerulus, tubulointerstitium and vasculature were analyzed for associations with relapse.RESULTS: During a median 50.9 months, 96.1% (49 of 51) of patients had achieved complete remission, and the rest ultimately achieved at least partial remission. A total of 56.9% (29 of 51) patients experienced at least 1 episode of relapse after the first remission. Patients with relapse had a higher rate of glomerular hypertrophy (GH; 34.5%) than those without relapse (9.1%; p < 0.05). After adjusting for confounders, GH was associated with increased odds of relapse (OR 15.992; 95% CI 1.537-166.362; p = 0.02). In a subgroup analysis according to median age, sex and tubulointerstitial (TI) lesions, the association between GH and relapse was evident only in men and in the group with TI lesions.CONCLUSION: GH is associated with relapse in adult patients with MCD, particularly in men and in those with TI lesions. Frequent monitoring and early intervention are needed in these groups. Future large prospective cohort studies are needed to confirm the study results.

UR - http://www.scopus.com/inward/record.url?scp=84949575404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949575404&partnerID=8YFLogxK

U2 - 10.1159/000442680

DO - 10.1159/000442680

M3 - Article

C2 - 26641085

AN - SCOPUS:84949575404

VL - 132

SP - 43

EP - 50

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 1

ER -